Isaura Santos graduated with a BS in Cell and Molecular Biology from Universidade Nova de Lisboa and a MA in Communication, Culture and Information Technologies from University Institute of Lisbon (ISCTE-IUL). Her professional interests include science communication, public awareness of science and communication of science through entertainment.
Seattle Children’s announced the opening of their new clinical trial to advance immunotherapy research in children suffering with neuroblastoma, the deadliest form of cancer in children. The Food and Drug Administration ... Read more
OncoSec Medical Inc. will present clinical results evaluating the company’s ImmunoPulse immunotherapy at Melanoma Bridge 2014. The event will be held in Naples, Italy, at the Royal Continental Hotel. The company has ... Read more
Bristol-Myers Squibb Company has announced results from the Phase 2 single-arm CheckMate-063 study, an open-label trial evaluating Opdivo (nivolumab) in patients with advanced squamous cell non-small cell lung cancer (NSCLC). Data will be presented today at the 2014 Chicago Multidisciplinary Symposium ... Read more
A “Breakthrough Therapy” designation was granted by the Food and Drug Administration (FDA) to Merck’s Keytruda for the treatment of non-small cell lung cancer patients whose disease continued progressing on or following platinum-based chemotherapy. Pembrolizumab ... Read more
The HuMab 5B1 antibody has been announced as a clinical candidate to diagnose and treat pancreatic and colon cancer by MabVax Therapeutics Holdings, Inc., a clinical stage oncology drug development ... Read more
A new clinical research collaboration to evaluate potential treatment options for acute and chronic leukemia has been announced by Bristol-Myers Squibb Company and The University of Texas MD Anderson Cancer Center. ... Read more